Nabriva scores its first FDA nod with novel antibiotic Xenleta by Kyle Blankenship Monday, August 19, 2019 With drug-resistant bacteria on the rise, antibiotics have struggled to keep up. But with an FDA nod for Nabriva's Xenleta, some of that may change.
